RGCC @RGCCGroup

How long can a #cancer cell line be cultured before its gene expression starts to drift, and why does it matter for research? 📄Read the latest publication from our research team: micropublication.org/journals/biolo…

Throwback post for our in-depth review published in February 2024 by #RGCC scientists on survival analysis methods in clinical studies. This article explores both introductory and advanced techniques in survival modeling. Read it here: ar.iiarjournals.org/content/44/2/4…

Developed through a collaboration between scientists & oncologists, our 2025 study examines the optimal strategy for adjusting second-line treatment for advanced pancreatic #cancer using circulating #tumor cells. You can read all our studies here rgcc-international.com/published-arti…

A conducted real-world study shows that CTC analysis can guide personalized treatment and improve outcomes for women with advanced or recurrent ovarian #cancer. 🔬Read it here: sciencedirect.com/science/articl…

If you or someone who love has CANCER, I urge you to look into an amazing test called RGCC. This test, takes a sample of your blood, analyzes it, breaks down its genetic sequence, and then gives the following pieces of information: 1. Circulating tumor cell count (CTC) 2. Specific Gene markers/aggressiveness 3. Which specific types of chemotherapy agents are effective against the cancer, which are ineffective, including percentages of effectiveness against your personal specific cancer. 4. Additionally, it will check over 100 non-traditional treatment options (including things like vitamin C, curcumin, mistletoe etc), to see if they are effective against your personal specific cancer. You can even add up to five additional compounds to have them check against your cancer, including the current favorites, ivermectin, fenbendazole, and mebendazole. There are 5 different tests to choose from, depending on the goal of the test. There is some coordination involved, but a simple blood draw and after about three weeks of testing, a full extensive summary is provided to you, your oncologist/team of physicians. The company actually will spend plenty of time explaining and breaking down the test to the providers as well, so that you know exactly how to approach your personalized treatment going forward. I know this is going to sound crazy, but the strong majority of oncologists have never heard of this test, I’ve spoken with several. Don’t worry they will - this is the future of cancer treatment. This is going to shake the industry - in a good way. This is Personalized cancer treatment at its finest. Gone are the days of ‘guessing’ if a treatment plan is effective against a specific cancer. This test allows you to measure and calculate, not guess. For those wondering they have a ‘screening’ test as well using the same techniques. The good news is that it’s not crazy expensive, on average the test runs about $2,500-4,000 depending specifics. Here is an example of the results for one of my patients that I saw yesterday with stage 4 lung cancer at 31 years old. I don’t have any affiliations with RGCC. This isn’t a paid advertisement. I do offer the test but many providers do. My goal is to share information to help people make better decisions about their health!

As part of its CSR activities, RGCC donates €15,000 to support CAR-T Cell therapy research at Charité – Universitätsmedizin Berlin. Read the full press release: rgcc-international.com/news/donation-…

RGCC has announced the initiation of legal proceedings aimed at addressing the limited access of thousands of EU patients to EMA-approved ATMPs. Read the full statement here: rgcc-international.com/news/eu-equal-…

Στην RGCC ο Υπουργός Ανάπτυξης, κος Παναγιώτης Θεοδωρικάκος news247.gr/publi/stin-rgc…

In this groundbreaking episode of A Healthy Point of View, host Sam Tejada is joined by the CMO of Liquivida who is an interventional cardiologist, Dr. Christopher Davis and special guest Dr. Ioannis Papasotiriou, founder of RGCC Laboratories. Together, they dive deep into one of the most feared topics in health: cancer. Discover how cutting-edge liquid biopsy and gene expression testing from RGCC are revolutionizing early cancer detection—even at stage ZERO. Learn why conventional screenings may be outdated, and how personalized medicine, immune system analysis, and precision therapy are the future of oncology. Dr. Papasotiriou shares his personal journey, the power of OncoTrace and OncoDeclare tests, and the real clinical outcomes from RGCC’s work—including doubling survival time in late-stage cancers. This episode is a must-watch for anyone serious about proactive health, cancer prevention, and living longer, healthier lives. Learn about: • What is advanced cancer screening? • What is RGCC? • The problem with late-stage diagnosis • Dr. Davis’s experience detecting cancer early • Comparison with traditional cancer screenings • Personalized therapy & transcriptomics explained • Why gene expression matters in aggressiveness & treatment • Using AI & real-world data for drug development • Is this the future of cancer care? • Why RGCC avoids outside investors • Clinical data and survival outcome • Message to patients & doctors: Don't give up @RGCCGroup #AHealthyPointOfViewPodcast #AgeManagement #Wellness #Cancer #IoannisPapasotiriou #Screening #ChristopherDavis #Genetics #HealthTips #Tumor #HealthyTips #IVDrips #Liquivida #SamTejada #MAHA #IntegrativeMedicine #Biohack #WINNERGY

At RGCC, we support healthcare professionals in delivering precision #oncology through every stage of the patient journey, from early detection to long-term monitoring. 🧬Empower your clinical decisions with #RGCC’s suite of advanced tests: rgcc-international.com/tests/

At #RGCC, we believe that truly personalized cancer care begins with precision diagnostics. This testimonial highlights how informed decisions and expert-led protocols can make all the difference in treatment journeys. Read more testimonials here: rgcc-international.com/testimonials/

Introducing InVyomma Plus, #RGCC's groundbreaking test delving into the intricate world of the gut microbiome. 🔗Learn more: rgcc-international.com/tests/invyomma…

At #RGCC, excellence is at the core of everything we do. We’re proud to hold a range of prestigious certifications that reflect our commitment to the highest industry standards. 📷 Explore our full list of accreditations >> rgcc-international.com

How do liquid biopsies work? By detecting these markers, liquid biopsies can provide valuable insights into potential #cancer development, even before traditional methods show abnormalities. Watch this video to learn more: youtube.com/watch?v=GAipxj…

🧪 Step into the epicenter of innovation at our #RGCC labs in Halle, #Germany! Here, we specialize in molecular biology, cell biology, and protein chemistry—fields that are revolutionizing the future of #cancer care.

keyboard_arrow_left Previous keyboard_arrow_right Next

At #RGCC, our vision is clear: A world where #cancer treatment is truly personalized, harnessing the power of innovative technologies and insights to provide tailored solutions for every individual. Learn more >> rgcc-international.com

The Cancer Drug Discovery Research Award, supported by #RGCC and The Swiss Chemical Society is here to honor outstanding achievements in cancer drug discovery research. 👉Learn more: scg.ch/com.../pages/p… @SwissChemistry

Delve into the world of cancer drug discovery with our peer-reviewed article! 👉 From statistical analysis to co-expression networks, we're paving the way for more effective treatments. Discover all our publications via rgcc-international.com/published-arti…

RGCC SA joins the finest laboratories in the world accredited by the College of American @Pathologists. Learn more about our accreditations via rgcc-international.com

🏆 We're thrilled to highlight the array of certifications that hashtag#RGCC labs proudly hold, showcasing our ongoing dedication to maintaining the highest standards of quality and safety! 💼🔬 Check out our certifications on our website >> rgcc-international.com